Profil
Alan Hastings Drummond was the founder of Chroma Therapeutics Ltd. which was founded in 2000, where he held the title of Chief Scientific Officer.
Prior to that, he held the position of Principal at Ligand UK Ltd. from 1988 to 2000.
He also held the position of Principal at the University of Glasgow and the University of London.
Dr. Drummond received his doctorate degree from the University of Cambridge in 1976.
Anciens postes connus de Alan Hastings Drummond
| Sociétés | Poste | Fin |
|---|---|---|
| VERNALIS | Corporate Officer/Principal | 01/01/2000 |
University of London
University of London Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
University of Glasgow
University of Glasgow Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Chroma Therapeutics Ltd.
Chroma Therapeutics Ltd. BiotechnologyHealth Technology Engages in the discovery and development of therapies for the treatment of cancer and inflammation | Fondateur | - |
Formation de Alan Hastings Drummond
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Ligand UK Ltd.
Ligand UK Ltd. BiotechnologyHealth Technology Engages in research and development & sells pharmaceutical products | Health Technology |
University of Glasgow
University of Glasgow Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Cambridge
University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of London
University of London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Chroma Therapeutics Ltd.
Chroma Therapeutics Ltd. BiotechnologyHealth Technology Engages in the discovery and development of therapies for the treatment of cancer and inflammation | Health Technology |
















